Adverse events in patients with blood loss: a pooled analysis of 51 clinical studies from the celecoxib clinical trial database.
CONCLUSIONS: Clinically significant anemia/blood loss may have clinically important adverse consequences beyond the sequelae previously known to be associated with NSAID-related GI effects.
PMID: 22629288 [PubMed]
Source: Open Rheumatology Journal - Category: Rheumatology Tags: Open Rheumatol J Source Type: research
More News: Anemia | Celebrex | Clinical Trials | Databases & Libraries | Gastroenterology | Heart Attack | Pneumonia | Rheumatology | Study | Toxicology